![Xiong Cai](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermogen: 189 M $ op 30-06-2026
Mr. Xiong Cai is a Director & Deputy General Manager at BeBetter Med, Inc. He is on the Board of Directors at BeBetter Med, Inc. He received his graduate degree from Shanghai Medical College of Fudan University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
BEBETTER MED, INC. 9,94% | 28-10-2025 | 40.095.146 ( 9,94% ) | 189 M $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| BEBETTER MED INC. | Directeur/Bestuurslid | 01-03-2013 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 2 |
|---|---|
Shanghai Medical College of Fudan University
 Shanghai Medical College of Fudan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BeBetter Med, Inc.
 BeBetter Med, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company and develops drugs for oncology, autoimmune and metabolic diseases | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau
Kies MarketScreener 
